2022年江西省罕见病治疗费用核算分析——基于SHA2011.pdfVIP

[成本与费用]

卫生经济研究第42卷第2期（总第454期）2025年2月

2022年江西省罕见病治疗费用核算分析

基于SHA2011

刘慧玲，赵恒伯，谢志勤”，昊海波

【摘要】目的：分析2022年江西省罕见病治疗费用及其影响因素,为完善罕见病防治策略提供参考。方法：基

于sHA2011理论和方法，核算分析2022年江西省罕见病治疗费用,采用K-Means聚类和支持向量机模型分析罕见病

院天数和药占比。结论：加强罕见病药品研发与药品供应保障，优化老年、儿童及重点病种的罕见病治疗策略，提高

基层罕见病诊疗能力,确保罕见病患者能够得到及时、有效的治疗。

【关键词】罕见病；治疗费用；卫生费用核算体系2011；江西省

中图分类号：R19文献标识码：A

AnalysisofRareDi#seTreatmentCostAccountil1iProvincein2022

BasedonSHA2011

LIUHuiling,ZHAOHengbo,XIEZhiqin,WUHaibo

Abstract:ObjectiveToanalyzethecostofrarediseasetreatmentanditsinfluencingfactorsinJiangxiProvincein2022,andtopro-

videreferenceforimprovingthestrategyofrarediseasepreventionandtreatment.MethodsBasedonthetheoryandmethodofSHA2011,

thetreatmentcostofrarediseasesinJiangxiProvincein2022wasanalyzed,andtheinfluencingfactorsofhospitalizationcostofraredis-

easeswereanalyzedbyK-Meansclusteringandsupportvectormachinemodel.ResultsIn2022,thetreatmentcostofrarediseasesin

JiangxiProvincewas67.1182millionyuan.theinstitutionalflowwasmainlyingeneralhospitalsandprovincialhospitals,thedistributionof

patientswasmainlyintheagegroupsof55-59yearsoldandunder20yearsold,andneurologicaldiseasesaccountedforthehighestcost,

andthemostimportantfactorsaffectingthecostofhospitalizationforrarediseasesweretheactualhospitalizationdaysandtheproportionof

drugs.ConclusionItisnecessarytostrengthentheresearchanddevelopmentofrarediseasedrugsanddrugsupplyguarantee,optimizethe

treatmentstrategyofrarediseasefortheelderly,childrenandkeydiseases,andimprovethediagnosisandtreatmentcapacityofraredis-

easeatprimaryleve